about
Development and validation of a clinical scale for rating the severity of blepharospasm.Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A.Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.Development of the Comprehensive Cervical Dystonia Rating Scale: MethodologyClinimetric testing of the comprehensive cervical dystonia rating scale.Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.Globus pallidus deep brain stimulation for adult-onset axial dystonia.The focal dystonias: current views and challenges for future researchDesigning clinical trials for dystonia.The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.Therapeutic advances in dystonia.Pial Synangiosis Ameliorates Movement Disorders in the Absence of Prior Stroke in Moyamoya Disease.Blepharospasm in children and adolescents.Unmet Needs in Dystonia: Genetics and Molecular Biology-How Many Dystonias?Blepharospasm 40 years later.Neck Pain and Cervical Dystonia: Treatment Outcomes from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.Cervical dystonia and quality of life.Cervical sensorimotor control in idiopathic cervical dystonia: A cross-sectional study.Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®.Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1.Measuring Disability in Patients With Cervical Dystonia According to the International Classification of Functioning, Disability and Health.Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".Normalization of sensorimotor integration by repetitive transcranial magnetic stimulation in cervical dystonia.Quantitative gait analysis in parkin disease: Possible role of dystonia.Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin.Rating Scales for Movement Disorders With Sleep Disturbances: A Narrative Review.Quantitative Assessment of ADL: A Pilot Study of Upper Extremity Reaching Tasks
P2860
Q27333214-1011C9E9-F3BE-4C85-A96D-B2402D2CDC7BQ34364973-10A5BDEF-472F-419E-9C6B-1759E73DAA96Q35694486-A4D178A5-4632-4DE3-AF02-0C5F8E4F0336Q36171693-7DB992C4-4EF4-41CF-B13A-7CF6AFFD7ACAQ36785510-1E58CCDD-F6F9-443D-A82D-288159D0315CQ36803313-0EACBF7B-CDF7-4CCE-ABCC-881C0E355768Q36856027-0C504203-2766-4B34-AAD2-D4873E2385E1Q36934949-D74F2F21-BB01-4AB0-8A04-1821C3EEAEEBQ37070290-D8DA0AD8-16E5-4B18-BB84-3C3C0A681817Q37506514-47B2DEF8-37F0-4C19-B972-A9B474024307Q38177641-DF611E5D-5366-4AAF-BC52-544A005C186AQ38572489-DB569AA0-6141-47F8-9D11-C78BCAB32A4DQ38602777-C9E26B25-6F74-48F3-8E2F-2384B5EC3311Q38618608-67CB488C-CDCF-4FA0-99A3-EADD27EF401EQ39110426-5FA3050C-5ACA-49C5-977A-8A30FF39CC5FQ39130169-B5947F3D-505B-46FD-AE43-8C299B4242B6Q39176166-D44172C2-3BAB-46F1-8D70-AEE92421C6A9Q40068279-7617AFFC-6176-4F54-96EE-251BD5582E98Q40772261-74E6FE5D-8F2C-4885-B4A8-2AA432061EBCQ41691281-CC8850AC-4EFC-4D2A-8915-00969FA59600Q43697542-57187CA4-0457-4581-BB21-BFD35BB3F5E5Q47178425-F2D7E2D5-4B99-4402-8621-839279E00798Q47691774-47136758-533F-4E48-BF26-8C45757F1D36Q47729274-CFF39D92-710C-49C1-AD44-C6773105541DQ47897706-54C10177-6EB7-4F88-9289-F3A20ADF6D4DQ48087724-46DA3CE6-74BB-4E24-BF6D-F11712DF1954Q48157817-C3980FC2-A673-4579-BEFC-5333CCA57B0EQ51660183-1127C5C7-EC47-4AD8-B012-E15B87AF258EQ53509186-750D4EAB-5F37-4AAC-8FA2-DF2E84FA1C5DQ55283577-D8A09E51-D97C-4507-B8E9-DC22E74911E9Q59114335-776EC600-4AFA-4E10-884F-A4EDC7189809
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Dystonia rating scales: critique and recommendations
@ast
Dystonia rating scales: critique and recommendations
@en
Dystonia rating scales: critique and recommendations
@nl
type
label
Dystonia rating scales: critique and recommendations
@ast
Dystonia rating scales: critique and recommendations
@en
Dystonia rating scales: critique and recommendations
@nl
prefLabel
Dystonia rating scales: critique and recommendations
@ast
Dystonia rating scales: critique and recommendations
@en
Dystonia rating scales: critique and recommendations
@nl
P2093
P2860
P50
P356
P1433
P1476
Dystonia rating scales: critique and recommendations
@en
P2093
Albert F G Leentjens
Alberto Albanese
Cynthia Comella
Francesca Del Sorbo
Glenn T Stebbins
H A Jinnah
Jens Volkmann
Jonathan W Mink
Thomas T Warner
P2860
P304
P356
10.1002/MDS.25579
P407
P577
2013-06-01T00:00:00Z